Cover Image
市場調查報告書

置入式輸液幫浦:開發中產品分析

Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 358889
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
置入式輸液幫浦:開發中產品分析 Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年06月01日 內容資訊: 英文 38 Pages
簡介

本報告提供目前開發中的置入式 (樹叢型) 輸液幫浦之開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等系統性資訊。

第1章 目錄

第2章 簡介

  • 置入式輸液幫浦概要

第3章 開發中的產品

  • 置入式輸液幫浦 - 開發中產品:各開發階段
  • 置入式輸液幫浦 - 開發中產品:各地區
  • 置入式輸液幫浦 - 開發中產品:各法規途徑
  • 置入式輸液幫浦 - 開發中產品:各核准時期 (預定)

第4章 置入式輸液幫浦:開發中的開發中產品 (各企業)

  • 置入式輸液幫浦企業 - 開發中產品:各開發階段
  • 置入式輸液幫浦 - 開發中產品:各開發階段

第5章 置入式輸液幫浦企業與產品概要

  • Alnylam Pharmaceuticals, Inc.
  • Debiotech S.A.
  • Delpor, Inc.
  • Eksigent Technologies, LLC
  • Eli Lilly and Company
  • Flowonix Medical, Inc.
  • FluidSynchrony, LLC
  • Intarcia Therapeutics, Inc.
  • Medallion Therapeutics, Inc.
  • Nano Precision Medical
  • Pharmaco-Kinesis Corporation
  • University of Minnesota
  • University of Southern California

第6章 置入式輸液幫浦:最近的趨勢

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's Medical Devices sector report, "Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2017" provides an overview of Implantable Infusion Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Infusion Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Implantable Infusion Pumps under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Infusion Pumps under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Implantable Infusion Pumps Overview 6

3 Products under Development 7

  • 3.1 Implantable Infusion Pumps - Pipeline Products by Stage of Development 7
  • 3.2 Implantable Infusion Pumps - Pipeline Products by Territory 8
  • 3.3 Implantable Infusion Pumps - Pipeline Products by Regulatory Path 9
  • 3.4 Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date 10
  • 3.5 Implantable Infusion Pumps - Ongoing Clinical Trials 11

4 Implantable Infusion Pumps - Pipeline Products under Development by Companies 12

  • 4.1 Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development 12
  • 4.2 Implantable Infusion Pumps - Pipeline Products by Stage of Development 13

5 Implantable Infusion Pumps Companies and Product Overview 14

  • 5.1 Alnylam Pharmaceuticals Inc Company Overview 14
    • 5.1.1 Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.2 Debiotech SA Company Overview 15
    • 5.2.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.3 Eksigent Technologies LLC Company Overview 17
    • 5.3.1 Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.4 Eli Lilly and Company Company Overview 18
    • 5.4.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.5 Flowonix Medical Inc Company Overview 19
    • 5.5.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.6 FluidSynchrony, LLC Company Overview 23
    • 5.6.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.7 Intarcia Therapeutics Inc Company Overview 24
    • 5.7.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.8 Medallion Therapeutics, Inc. Company Overview 26
    • 5.8.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 Nano Precision Medical Inc Company Overview 27
    • 5.9.1 Nano Precision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 University of Minnesota Company Overview 28
    • 5.10.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.11 University of Southern California Company Overview 29
    • 5.11.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 29

6 Implantable Infusion Pumps- Recent Developments 30

  • 6.1 Mar 14, 2017: Medtronic Announces Class I Recall for SynchroMed II Implantable Drug Infusion Pump 30
  • 6.2 Mar 14, 2017: Medtronic Announces Class I Recall For SynchroMed EL Implantable Drug Infusion Pumps 30
  • 6.3 Mar 14, 2017: Flowonix Medical And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy 31
  • 6.4 Feb 03, 2017: Intarcia Announces FDA Filing Acceptance of New Drug Application for ITCA 650 for the Treatment of Type 2 Diabetes 32
  • 6.5 Oct 28, 2016: Teleflex Incorporated Signs New Agreement with Premier for Implantable Infusion Ports 32
  • 6.6 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 32

7 Appendix 35

  • 7.1 Methodology 35
  • 7.2 About GlobalData 38
  • 7.3 Contact Us 38
  • 7.4 Disclaimer 38

List of Tables

1.1 List of Tables

  • Table 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development 7
  • Table 2: Implantable Infusion Pumps - Pipeline Products by Territory 8
  • Table 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path 9

Table

List of Figures

1.2 List of Figures

  • Figure 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development 7
  • Figure 2: Implantable Infusion Pumps - Pipeline Products by Territory 8
  • Figure 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path 9
  • Figure 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date 10
  • Figure 5: Implantable Infusion Pumps - Ongoing Clinical Trials 11
Back to Top